Active Ingredient: Niraparib Tosylate Monohydrate
Nirib 100mg is a targeted therapy for adult patients with ovarian epithelial, fallopian tube, or primary peritoneal cancer. This advanced treatment works by inhibiting an enzyme essential for numerous cellular functions, including the repair of damaged DNA. By blocking this enzyme, Nirib 100mg helps prevent the growth and spread of cancer cells, making it an effective choice in specific cancer therapies. Niraparib Tosylate Monohydrate is also being researched for its potential in treating other types of cancer.
Indication:
- Ovarian Epithelial Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Cancer
Mechanism of Action:
Nirib 100mg targets and inhibits DNA repair mechanisms in cancer cells, limiting their ability to survive and proliferate.
Advantages:
-
Targeted Cancer Therapy:
-
Effective for Multiple Cancer Types:
-
It is approved for treating ovarian epithelial, fallopian tube, and primary peritoneal cancers, offering versatility in cancer management.
-
Oral Administration:
-
Potential for Broader Applications:
-
Slows Cancer Progression:
Disadvantages:
-
Side Effects:
-
Common side effects include nausea, fatigue, anemia, and thrombocytopenia (low platelet counts), which can impact patients' quality of life during treatment.
-
Not Suitable for All Cancer Types:
-
Potential for Resistance:
-
High Cost:
-
As with many cancer treatments, Nirib 100mg can be expensive, and affordability might be an issue for some patients, depending on their healthcare coverage.
-
Risk of Severe Complications:
-
Serious side effects, though less common, may include bone marrow suppression, gastrointestinal issues, and cardiovascular problems, which require close monitoring by healthcare professionals.
Dosage Form: 100mg Tablets
Consult your healthcare provider for detailed dosage instructions and to understand potential side effects.